New VC bioqube on open innovation roots and investments targets

Nico Vandervelpen, managing partner and co-founder of bioqube ventures—a Johnson & Johnson-partnered venture capital company—chats with Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about the young VC’s big plans for the future. Vandervelpen explains the benefits of bioqube's relationship with J&J's JLINX incubator, the VC's open innovation mentality and what it wants to see from startups seeking investment.

[video src="https://www.youtube.com/embed/zIW3EL95tzE"]

Interviewer: Mike Ward – Global Director of Content, Pharma Intelligence, In Vivo/Pink Sheet/Scrip
Interviewee: Nico Vandervelpen – Managing Partner, bioqube ventures